Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-01 Tax Withholding | 2026-10-05 4:12 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,047 | $3.94 | 43,529 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-06 6:00 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,047 | $7.8 | 44,576 (Direct) | View |
| 2026-05-10 Option Award | 2026-05-12 4:11 pm | N/A 2036-05-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,103,837 | $0 | 1,103,837 (Direct) | View |
| 2026-04-01 Tax Withholding | 2026-05-05 7:03 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro President and CEO | 1,047 | $9.03 | 45,623 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 4:57 pm | N/A 2036-03-09 | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro Chief Scientific Officer | 256,670 | $0 | 256,670 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-28 4:39 pm | N/A 2035-08-25 | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro Chief Scientific Officer | 357,177 | $0 | 357,177 (Direct) | View |
Ownership | 2025-08-18 5:07 pm | N/A 2034-07-22 | BridgeBio Oncology Therapeutics Inc. | BBOT | Beltran Pedro Chief Scientific Officer | 0 | $0 | 469,849 (Direct) | View |